About this trial
Effect of acute exercise testing in pregnant athletes on maternal and fetal heart rate, fetal/maternal bloodflow and cardiotocogramm assessment.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Presence of signed informed consent form
healthy pregnant active female over the age of 18 years and below 45 years
sporting activity >4h/week on 2 or more weekdays
single pregnancy, between 28+0 and 34+0 weeks of pregnancy
Disqualifiers
No signed informed consent form or revocation of consent
pre-existing pregnancy complications
Trial population
pregnant athletes
Trial design
Cohort
Prospective
Treatments tested in this trial
exercise testing
Other interventionincremental cycling test on a bicycle ergometer
Treatment groups
Trial outcomes
Primary outcomes
fetal heart rate
The fetal heart rate is continuously monitored via the CTG device during the entire performance test.
Secondary outcomes
Umbilical cord artery pulsatility index
(systolic velocity - diastolic velocity) / mean velocity
Umbilical cord artery resistance index
(systolic velocity - diastolic velocity) / systolic velocity
umbilical cord artery S/D ratio
(S = maximum systolic flow velocity; D = maximum diastolic flow velocity)
Medial cerebral artery pulsatility index
(systolic velocity - diastolic velocity) / mean velocity
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Balgrist University Hospital
Lead sponsor
University Hospital, Zürich
Collaborator